Drug Shortage Report for HALOETTE
| Report ID | 266226 |
| Drug Identification Number | 02520028 |
| Brand name | HALOETTE |
| Common or Proper name | Haloette |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETONOGESTREL ETHINYL ESTRADIOL |
| Strength(s) | 11.7MG 2.7MG |
| Dosage form(s) | RING (SLOW-RELEASE) |
| Route of administration | VAGINAL |
| Packaging size | 1 ring |
| ATC code | G02BB |
| ATC description | CONTRACEPTIVES FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-11-21 |
| Actual start date | |
| Estimated end date | 2026-07-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-11-22 | English | Compare |
| v5 | 2025-11-06 | French | Compare |
| v4 | 2025-11-06 | English | Compare |
| v3 | 2025-11-01 | English | Compare |
| v2 | 2025-08-29 | French | Compare |
| v1 | 2025-08-29 | English | Compare |
Showing 1 to 6 of 6